These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 516016)

  • 1. [Musculoskeletal symptoms in patients with primary hyperlipoproteinemia. A prelimary study].
    Brekke SE; Kogstad OA
    Tidsskr Nor Laegeforen; 1979 Oct; 99(29):1444-6. PubMed ID: 516016
    [No Abstract]   [Full Text] [Related]  

  • 2. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis].
    Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R
    Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Subfractions of HDL cholesterol. Occurrence in hyperlipoproteinemia type IIa and IV].
    Mertz DP; Thuilot G; Bürvenich K
    Fortschr Med; 1986 Jul; 104(26):508-10. PubMed ID: 3744260
    [No Abstract]   [Full Text] [Related]  

  • 4. [Primary hyperlipoproteinemia in its clinical and laboratory aspects. VII. Phonoangiographic study].
    Szmatłoch E; Olejak B; Gregorczyk J; Pieczul-Mróz J; Brzeźniak R; Ansilewski K; Jagła A; Kutrzeba J
    Przegl Lek; 1984; 41(2):213-6. PubMed ID: 6739839
    [No Abstract]   [Full Text] [Related]  

  • 5. [Localization of vessel lesions in arteriosclerosis and blood lipid composition].
    Lipovetskiĭ BM; Vinogradova TV
    Ter Arkh; 2002; 74(2):55-7. PubMed ID: 11899828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary hyperlipoproteinemia in its clinical and laboratory aspects. IV. Blood coagulation and fibrinolysis indicators].
    Borodin M; Jurek D; Gregorczyk J; Pieczul-Mróz J; Cwajda H
    Przegl Lek; 1983; 40(10):727-32. PubMed ID: 6665208
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelets intravascular coagulation and fibrinolysis in hyperlipidaemias: relationship to thrombo-embolic complications.
    Carvalho AC; Lees RS
    Acta Med Scand Suppl; 1980; 642():101-12. PubMed ID: 6935936
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cholesterol and triglyceride plasma levels in patients with primary hyperlipoproteinemia. Decline after short-term i.v. glucagon administration].
    Andĕl M; Brodan V; Kucerová L; Grafnetter D; Kuhn E; Veselková A
    Cas Lek Cesk; 1980 May; 119(22):616-21. PubMed ID: 7427980
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case of xanthomatous tendinopathy].
    Chiarelli G; Faccini R; Massari L
    Chir Organi Mov; 1986; 71(2):169-72. PubMed ID: 3802995
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyperlipoprotein phenotypes as risk factors in ischemic cardiopathy. II. Clinical aspects].
    Walter-Rosianu A
    Rev Pediatr Obstet Ginecol Pediatr; 1984; 33(2):145-60. PubMed ID: 6429817
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of n-3 fatty acids on lipids and haemostasis in patients with type IIa and type IV hyperlipidaemia.
    Schmidt EB; Ernst E; Varming K; Pedersen JO; Dyerberg J
    Thromb Haemost; 1989 Sep; 62(2):797-801. PubMed ID: 2814927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary results of sulodexide treatment in patients with peripheral arteriosclerosis and hyperlipidemia. A multicentre trial.
    Crepaldi G; Fellin R; Calabrò A; Baiocchi MR; Rossi A; Lenzi S; Descovich GC; Delmonte G; Gaddi A; Ventura A
    Monogr Atheroscler; 1986; 14():215-21. PubMed ID: 3526129
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical characteristics of primary hyperlipoproteinemia type IV. An analysis of 86 patients].
    Kusić M; Gavrilović M; Mihajlović M; Marković N
    Zb Vojnomed Akad; 1981; 23():15-9. PubMed ID: 6963834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipoprotein lipase activity of ischemic heart disease patients with different types of hyperlipoproteinemia on the basis of fat loading].
    Nikul'cheva NG; Soliternova IB; Krivoruchenko IV
    Vopr Med Khim; 1980; 26(6):808-13. PubMed ID: 7456412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrinolytic capacity after exertion in atherogenic hyperlipoproteinemias].
    Zdrenghea D; Mărcuşu C; Cucuianu M; Rentsch S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):435-40. PubMed ID: 44567
    [No Abstract]   [Full Text] [Related]  

  • 16. [Behavior of serum lipids, blood coagulation factors, platelet aggregation, complement and serum immunoglobulins in a group of arteriosclerotic, hyperlipemic subjects treated with 3GS].
    D'Eredità F; Avellone G; Novo S; Davì G; Abruzzese G; Di Liberti M; Pinto A; Riolo F
    Clin Ter; 1981 Feb; 96(3):303-24. PubMed ID: 7307448
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contrast-unloading week in the complex therapy of patients with metabolic-alimentary obesity and its effect on changes in body weight and lipid metabolism indices].
    Loĭko VI; Baketova NN; Lebedeva EA; Kolmakov VN; Skovorodnikova ES
    Vopr Pitan; 1979; (5):30-3. PubMed ID: 516598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk in patients with treated familial hypercholesterolaemia and patients with severe hypertriglyceridaemia.
    Way BP; Ball MJ; Thorogood M; Cobbe SM; Mann JI
    J R Soc Med; 1986 Jul; 79(7):391-4. PubMed ID: 3746800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks.
    Otto C; Ritter MM; Richter WO; Minkenberg R; Schwandt P
    Metabolism; 2001 Feb; 50(2):166-70. PubMed ID: 11229424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipids and smoking habit in first degree relatives of patients of ischaemic heart disease.
    Vajpayee A; Chadda VS; Jain NC; Mishra SN; Sulemani AA; Singhvi DR
    Indian Heart J; 1981; 33(6):274-6. PubMed ID: 7341399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.